Stockton Hematology Oncology Medical Group (SHOMG) - Stockton (Suite B)

Clinical research site in Stockton, California

Part of Stockton Hematology Oncology Medical Group

As of July 2026, 1 paid clinical trial is recruiting at Stockton Hematology Oncology Medical Group (SHOMG) - Stockton (Suite B) in Stockton, California. Active studies at this site cover conditions such as Advanced Non-Small Cell Lung Cancer and Metastatic Non-Small Cell Lung Cancer. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.

Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: July 19, 2026.

Recruiting clinical trials at Stockton Hematology Oncology Medical Group (SHOMG) - Stockton (Suite B) (1)

Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7

for Advanced Non-Small Cell Lung Cancer

192 locations incl. Goodyear

Sponsor: Mirati Therapeutics Inc.

Sex: All·Age: 18+

Code: NCT04613596·Phase 2, Phase 3·Recruiting·Listed Nov 2020

Apply to this trial

Explore more

Paid clinical trials in Stockton, CA · California clinical trials

Stockton Hematology Oncology Medical Group (SHOMG) - Stockton (Suite B)

Recruiting clinical trials at Stockton Hematology Oncology Medical Group (SHOMG) - Stockton (Suite B) (1)

Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7

More research sites in Stockton

Explore more